Global Autoimmune Disease Market Size study, by Disease Type (Localized, Systemic), by Diagnostic (IFA, ELISA, Dot blot, Line Blot, Agglutination, Double Immune Diffusion, Western Blotting, Multiplex Immunoassay, Others), by Product (Drugs, Therapeutic & Monitoring Equipment, Diagnostic Equipment) and Regional Forecasts 2018-2025
![](/report_cover/10760/global-autoimmune-disease-market-size-study-by-disease-type-by-diagnostic-by-product-regional-forecasts-2018-2025_en.gif)
Global Autoimmune Disease Market to reach USD XX billion by 2025.
Global Autoimmune Disease Market valued approximately USD 37.81 billion in 2017 is anticipated to grow with a healthy growth rate of more than 3.82% over the forecast period 2018-2025. The Autoimmune Disease Market is continuously growing in global scenario over the coming years. The major driving factor of global Autoimmune Disease market is increasing incidence of chronic diseases and development of novel biomarkers such as Enbrel & Humira. In addition, improvement in regulatory framework, technological enhancements, and growing government assistance are also some other major factors which propelling the growth of the market. However, High treatment cost, poorly trained physicians and emergence of alternative technologies are some major factors which limiting the market growth. Autoimmune disease is a condition in which immune system mistakenly attacks body. These diseases cause dissimilarities in organ functioning, anomalous growth of organs and destruction of vigorous body. These disease are habitually chronic in nature and there is no remedial therapy. The common autoimmune diseases are Type 1 diabetes, Rheumatoid arthritis, Psoriasis/Psoriatic arthritis, Multiple sclerosis, Systemic lupus erythematous (lupus), Inflammatory bowel diseases, Myasthenia gravis, Vasculitis, Celiac disease and so on. Various types of treatment for theses diseases include physical therapy, blood transfusion, recombinant technology, chemo therapy, topical therapy, TNF-a antagonists and Helminthic.
The regional analysis of Global Autoimmune Disease Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing investment in R&D and increasing awareness among people related to healthcare. Europe is also estimating to project a major growth in the global Autoimmune Disease market due to increasing disposable income of individuals in the region. Asia-Pacific is also anticipated to exhibit higher growth rate/CAGR over the forecast period 2018-2025 due to improving health infrastructure and increasing aging population.
The major market player included in this report are:
By Disease Type:
Global Autoimmune Disease Market valued approximately USD 37.81 billion in 2017 is anticipated to grow with a healthy growth rate of more than 3.82% over the forecast period 2018-2025. The Autoimmune Disease Market is continuously growing in global scenario over the coming years. The major driving factor of global Autoimmune Disease market is increasing incidence of chronic diseases and development of novel biomarkers such as Enbrel & Humira. In addition, improvement in regulatory framework, technological enhancements, and growing government assistance are also some other major factors which propelling the growth of the market. However, High treatment cost, poorly trained physicians and emergence of alternative technologies are some major factors which limiting the market growth. Autoimmune disease is a condition in which immune system mistakenly attacks body. These diseases cause dissimilarities in organ functioning, anomalous growth of organs and destruction of vigorous body. These disease are habitually chronic in nature and there is no remedial therapy. The common autoimmune diseases are Type 1 diabetes, Rheumatoid arthritis, Psoriasis/Psoriatic arthritis, Multiple sclerosis, Systemic lupus erythematous (lupus), Inflammatory bowel diseases, Myasthenia gravis, Vasculitis, Celiac disease and so on. Various types of treatment for theses diseases include physical therapy, blood transfusion, recombinant technology, chemo therapy, topical therapy, TNF-a antagonists and Helminthic.
The regional analysis of Global Autoimmune Disease Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing investment in R&D and increasing awareness among people related to healthcare. Europe is also estimating to project a major growth in the global Autoimmune Disease market due to increasing disposable income of individuals in the region. Asia-Pacific is also anticipated to exhibit higher growth rate/CAGR over the forecast period 2018-2025 due to improving health infrastructure and increasing aging population.
The major market player included in this report are:
- Abbott Laboratories
- Active Biotech
- Eli Lilly
- Bristol-Myers Squibb
- AstraZeneca plc
- Pfizer
- Biogen Idec
- Lupin Limited
- GlaxoSmithKline
- Amgen
- 4SC
- F. Hoffmann-La Roche Ltd.
- AutoImmune Inc.
- Johnson & Johnson
- Bayer
By Disease Type:
- Localized
- Systemic
- IFA
- ELISA
- Dot blot
- Line Blot
- Agglutination
- Double Immune Diffusion
- Western Blotting
- Multiplex Immunoassay
- Others
- Drugs
- Therapeutic & Monitoring Equipment
- Diagnostic Equipment
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Mexico
- Rest of the World
- Historical year – 2015, 2016
- Base year – 2017
- Forecast period – 2018 to 2025
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. Autoimmune Disease Market, by Disease Type, 2015-2025 (USD Billion)
1.3.2. Autoimmune Disease Market, by Diagnostics, 2015-2025 (USD Billion)
1.3.3. Autoimmune Disease Market, by Products, 2015-2025 (USD Billion)
1.3.4. Autoimmune Disease Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. AUTOIMMUNE DISEASE MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. AUTOIMMUNE DISEASE MARKET DYNAMICS
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. AUTOIMMUNE DISEASE MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
CHAPTER 5. AUTOIMMUNE DISEASE MARKET, BY DISEASE TYPE
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Key Market Players
5.4. Autoimmune Disease Market, Sub Segment Analysis
5.4.1. Localized
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. Systemic
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 6. AUTOIMMUNE DISEASE MARKET, BY DIAGNOSTICS
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Key Market Players
6.4. Autoimmune Disease Market, Sub Segment Analysis
6.4.1. IFA
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. ELISA
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Dot blot
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Line blot
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.5. Agglutination
6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.6. Double Immune Diffusion
6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.7. Western Blotting
6.4.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.8. Multiplex Immunoassay
6.4.8.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.8.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.9. Others
6.4.9.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.9.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 7. AUTOIMMUNE DISEASE MARKET, BY PRODUCT
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Key Market Players
7.4. Autoimmune Disease Market, Sub Segment Analysis
7.4.1. Drugs
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. Therapeutic & Monitoring Equipment
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Diagnostic Equipment
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 8. AUTOIMMUNE DISEASE MARKET, BY REGIONAL ANALYSIS
8.1. Autoimmune Disease Market, Regional Market Snapshot (2015-2025)
8.2. North America Autoimmune Disease Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Autoimmune Disease Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. France
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4. Rest of Europe
8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Autoimmune Disease Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Latin America Autoimmune Disease Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
8.6.1. South America
8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2. Middle East and Africa
8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abbott Laboratories
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Active Biotech
9.3.3. Eli Lilly
9.3.4. Bristol-Myers Squibb
9.3.5. AstraZeneca plc
9.3.6. Pfizer
9.3.7. Biogen Idec
9.3.8. Lupin Limited
9.3.9. GlaxoSmithKline
9.3.10. Amgen
9.3.11. 4SC
9.3.12. F. Hoffmann-La Roche Ltd.
9.3.13. AutoImmune Inc.
9.3.14. Johnson & Johnson
9.3.15. Bayer
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. Autoimmune Disease Market, by Disease Type, 2015-2025 (USD Billion)
1.3.2. Autoimmune Disease Market, by Diagnostics, 2015-2025 (USD Billion)
1.3.3. Autoimmune Disease Market, by Products, 2015-2025 (USD Billion)
1.3.4. Autoimmune Disease Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. AUTOIMMUNE DISEASE MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. AUTOIMMUNE DISEASE MARKET DYNAMICS
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. AUTOIMMUNE DISEASE MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
CHAPTER 5. AUTOIMMUNE DISEASE MARKET, BY DISEASE TYPE
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Key Market Players
5.4. Autoimmune Disease Market, Sub Segment Analysis
5.4.1. Localized
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. Systemic
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 6. AUTOIMMUNE DISEASE MARKET, BY DIAGNOSTICS
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Key Market Players
6.4. Autoimmune Disease Market, Sub Segment Analysis
6.4.1. IFA
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. ELISA
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Dot blot
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Line blot
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.5. Agglutination
6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.6. Double Immune Diffusion
6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.7. Western Blotting
6.4.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.8. Multiplex Immunoassay
6.4.8.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.8.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.9. Others
6.4.9.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.9.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 7. AUTOIMMUNE DISEASE MARKET, BY PRODUCT
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Key Market Players
7.4. Autoimmune Disease Market, Sub Segment Analysis
7.4.1. Drugs
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. Therapeutic & Monitoring Equipment
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Diagnostic Equipment
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 8. AUTOIMMUNE DISEASE MARKET, BY REGIONAL ANALYSIS
8.1. Autoimmune Disease Market, Regional Market Snapshot (2015-2025)
8.2. North America Autoimmune Disease Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Autoimmune Disease Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. France
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4. Rest of Europe
8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Autoimmune Disease Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Latin America Autoimmune Disease Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
8.6.1. South America
8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2. Middle East and Africa
8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abbott Laboratories
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Active Biotech
9.3.3. Eli Lilly
9.3.4. Bristol-Myers Squibb
9.3.5. AstraZeneca plc
9.3.6. Pfizer
9.3.7. Biogen Idec
9.3.8. Lupin Limited
9.3.9. GlaxoSmithKline
9.3.10. Amgen
9.3.11. 4SC
9.3.12. F. Hoffmann-La Roche Ltd.
9.3.13. AutoImmune Inc.
9.3.14. Johnson & Johnson
9.3.15. Bayer
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption